Dow Up0.25% Nasdaq Up0.65%

More On LUPIN.NS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Lupin Limited (LUPIN.NS)

-NSE
1,480.10 Up 10.15(0.69%) May 27, 6:00AM EDT
ProfileGet Profile for:
Lupin Limited
Laxmi Towers, B Wing
Bandra Kurla Complex
Mumbai, 400051
India - Map
Phone: 91 22 6640 2222
Fax: 91 22 6640 2130
Website: http://www.lupinworld.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:N/A

Business Summary 

Lupin Limited, a pharmaceutical company, produces, develops, and markets a range of branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the areas of cardiovascular, diabetology, asthma, pediatric, central nervous system (CNS), gastro-intestinal, anti-diabetic, anti-infective, NSAID, anti- tuberculosis, cephalosporin, gynaecology, and other therapeutic areas; and APIs for use in therapeutic areas of antibiotics, anti-tuberculosis, cardiovascular, CNS, analgesics, and anti-gout. The company also develops drug delivery technologies; and creates and develops biosimilars for various therapeutic indications, such as oncology, inflammation, antivirals, osteoporosis, rheumatoid arthritis, and ophthalmics. In addition, it engages in the novel drug discovery and development programs for use in the treatment of CNS disorders, oncology, immunology, pain and inflammation, infections, and metabolic/endocrine disorders. Lupin Limited has a strategic licensing agreement with InspiRX Inc. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Lupin Limited

Key Executives 
 PayExercised
Dr. Desh Bandhu Gupta ,
Chairman of The Board, Founder, Chairman of Allotment Committee, Member of Share Transfer Committee and Member of Corp. Social Repsonsibility Committee
375.77MN/A
Dr. Kamal K. Sharma B.Eng (Chem) Ph.D., 67
Vice Chairman, Chairman of Share Transfer Committee, Chairman of Risk Management Committee, Member of Allotment Committee, Member of Audit Committee and Member of Corp. Social Repsonsibility Committee
141.59MN/A
Mr. Ramesh Swaminathan ,
Chief Financial Officer, Exec. Director and Member of Risk Management Committee
99.24MN/A
Mr. Rajvardhan V. Satam ,
Compliance Officer and Company Sec.
5.81MN/A
Mrs. Manju D. Gupta , 72
Exec. Director, Member of Share Transfer Committee and Member of Allotment Committee
5.05MN/A
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.